Humacyte Inc.-CW27HUMAWPreferred / convertible

13F holders, Q4 2024 (December 31)
5holders −2
1new positions
2sold out
$1.82avg. 13F price*

At the end of Q4 2024, 5 institutions reported holding Humacyte Inc.-CW27 (HUMAW) in their 13F filings, down 2 from Q3 2024. 1 opened new positions and 2 sold out. The largest holders were LPL Financial LLC ($543K), Sio Capital Management, LLC ($92K) and Jane Street Group, LLC ($91K).

Company
Humacyte Inc.-CW27
CUSIP
44486Q111
Latest filing quarter
Q2 2026

History

Number of 13F holders

0246810 Q1 2024: 6Q1 2024Q2 2024: 10Q2 2024Q3 2024: 7Q3 2024Q4 2024: 5Q4 2024Q1 2025: 5Q1 2025Q2 2025: 6Q2 2025Q3 2025: 6Q3 2025Q4 2025: 8Q4 2025Q1 2026: 7Q1 2026Q2 2026: 8Q2 2026

Total Exit/New Position Q3 2024 → Q4 2024

InstitutionsTotal Value
New Positions1$22K
Exits2$41K

All 13F filers, Q3 2024 → Q4 2024: 11,985 shares bought and 53,702 shares sold, net −41,717 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 5 holders

LPL Financial LLC — Reduce -0.7% 298,480 $543K
Sio Capital Management, LLC — No change 49,998 $92K
Jane Street Group, LLC — Reduce -0.7% 50,000 $91K
Wolverine Asset Management LLC — Reduce -47.0% 32,035 $58K
Virtu Financial LLC — New 11,985 $22K

"% of holder's portfolio" is HUMAW's weight in each manager's 13F, not the share of Humacyte Inc.-CW27 the manager owns.